Latest News
Medicinal Cannabis in the news
You may have seen some attention in today’s media around medicinal cannabis...
My Health Record in the news (UPDATE)
Following the recent Federal Government opt out announcement, My Health Record is currently one of the most talked...
Book review: 'The Unmapped Mind' - Christian Donlan
Reviewed by Astrid Edwards
⭐️⭐️⭐️⭐️⭐️
My Health Record in the news
MS Australia continues to monitor with interest the progress of the Federal Government’s My Health Record.
Today’s...
Men’s Health Week 2018 – Making Health Connections
Whilst MS affects roughly three times as many women than men, recently released prevalence figures indicate that nearly 8000 men in Australia deal with MS on a daily basis. (1)
Research also indicates that the more severe and less treatable form of the condition – Primary progressive MS (...
WORLD MS DAY 2018 – This WEDNESDAY 30th May!
Global MS Community Spotlights Research
MS Australia, MS Research Australia, the four state/territory MS organisations and the international multiple sclerosis (MS) community will recognise World MS Day this Wednesday 30th May 2018.
...
MS Australia celebrates National Volunteer Week, 21-27 May 2018
The multiple sclerosis (MS) community in Australia is supported by thousands of generous volunteers. Without these volunteers, organisations such as MS Australia and the State/territory MS organisations couldn’t fundraise, offer services and support, or advocate to improve the lives of people...
International Nurses Day: Celebrating those very special specialists
This Saturday 12th May, sees us recognising International Nurses Day. It’s no coincidence that it’s also the birthday of the founder of modern nursing, Florence Nightingale.
For many of us in the MS community, this day is the perfect time to...
Budget 2018 - A mix of sweet and sour for the MS community
MS Australia (MSA) welcomes some sweet choices for people with multiple sclerosis (MS) in the 2018-19 Australian Budget, but mixed with some sour notes too.
We make the following specific observations:
HEALTH
MSA welcomes the...
PBS listing for MAVENCLAD® (cladribine tablets) for RRMS not recommended by PBAC
The Pharmaceutical Benefits Advisory Committee (PBAC) announced at 4pm today (20/4/18), they have not recommended the listing of MAVENCLAD® (cladribine tablets) for relapsing remitting MS (RRMS) on the Pharmaceutical Benefits Scheme (PBS).
The PBAC said that it, “did not recommend the...
